As previously reported, POLA1 was found to be a risk factor for HCC, and the underlying mechanism for this was the suppression of the antitumor immune response through IFN-γ inhibition (Starokadomskyy et al., 2016). Here, POLA1 is linked to hepatocellular carcinoma.